109992 ⎘
dsDNA viruses; Details; Poxviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
ENHANCING ONCOLYTIC VIROTHERAPY WITH A COMBINATION OF NUCLEAR EXPORT INHIBITOR AND MYXOMA VIRUS ACTIVATING CELL DEATH PATHWAYS
#2CANCER THERAPIES COMPRISING A NUCLEAR EXPORT INHIBITOR AND AN ONCOLYTIC VIRUS
#3AMINO ACIDS, NUCLEOTIDES AND VECTORS EXPRESSING THE SAME AND USES THEREOF IN PREVENTING SARBECOVIRUS INFECTION
#4Use of Ectromelia Virus for Cancer Immunotherapy and Vaccines
#5USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC
#6MULTI-ARMED MYXOMA VIRUS
#7NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS
#8Integral membrane protein display on poxvirus extracellular enveloped virions
#9Oncolytic virus platform to treat cancers with myxoma virus
#10Salmon gill poxvirus
#11Use of AAV-expressed M013 protein as an anti-inflammatory therapeutic
#12MVA virus and uses thereof
#13Viral Sequences and Uses Thereof
#14Nucleic acid molecules and polypeptides for immune modulation
#15LEPORIPOXVIRUS-DERIVED VACCINE VECTORS
#16Immunomodulatory protein and useful embodiments thereof
#17IMMUNOMODULATORY COMPOSITIONS AND USES THEREFOR
#18Immunomodulatory protein and useful embodiments thereof
#19Compositions and Methods for Elimination of Unwanted Cells
#20Compositions and Methods for Elimination of Unwanted Cells
#21Immunodeficiency recombinant poxvirus
#22Compositions and Methods for Elimination of Unwanted Cells
#23Compositions and methods for elimination of unwanted cells
#24Treatment of spinal cord injury
#25Immunomodulatory compositions and uses therefor
#26Nucleic acid molecules and polypeptides for immune modulation
#27Compositions and methods for elimination of unwanted cells
#28Use of vaccinia virus deleted for the E3L gene as a vaccine vector
#29Materials and methods for delivery and expression of heterologous DNA in vertebrate cells